EntryPoint Capital’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,535	Closed	-$183K	–	817
2024 Q4	$183K	Buy	+11,535	New	+$183K	0.08%	609
2024 Q1	–	Sell	-23	Closed	-$914	–	1595
2023 Q4	$914	Buy	+23	New	+$914	﹤0.01%	1290